| dc.date.accessioned | 2023-05-09T11:34:56Z | |
| dc.date.available | 2023-05-09T11:34:56Z | |
| dc.date.issued | 2020-04-02 | |
| dc.identifier.citation | National Centre for Pharmacoeconomics (NCPE Ireland), Medicines Management Programme (MMP), National Medicines Information Centre (NMIC), COVID-19 Evidence Review Group for Medicines, 'Clinical evidence for hydroxychloroquine and azithromycin combination therapy for COVID-19', [report], 2020-04-02 | en |
| dc.language.iso | en | en |
| dc.rights | Y | en |
| dc.subject | Covid-19 | en |
| dc.subject | Coronavirus | en |
| dc.subject | Hydroxychloroquine | en |
| dc.subject | Azithromycin | en |
| dc.subject | Combination therapy | en |
| dc.title | Clinical evidence for hydroxychloroquine and azithromycin combination therapy for COVID-19 | en |
| dc.type | report | en |
| dc.type.supercollection | edepositireland | |
| dc.contributor.corporatename | National Centre for Pharmacoeconomics (NCPE Ireland) | en |
| dc.contributor.corporatename | Medicines Management Programme (MMP) | en |
| dc.contributor.corporatename | National Medicines Information Centre (NMIC) | en |
| dc.contributor.corporatename | COVID-19 Evidence Review Group for Medicines | en |
| dc.publisher.place | IE | en |
| dc.description.version | Version 2 | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.relation.relatedto | TCD Covid-19 Collection | |
| dc.identifier.uri | http://hdl.handle.net/2262/102606 | |
